Literature DB >> 19505534

Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.

Jeffrey M Peters1, Frank J Gonzalez.   

Abstract

Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) has many beneficial physiological functions ranging from enhancing fatty acid catabolism, improving insulin sensitivity, inhibiting inflammation and increasing oxidative myofibers allowing for improved athletic performance. Thus, given the potential for targeting PPARbeta/delta for the prevention and/or treatment of diseases including diabetes, dyslipidemias, metabolic syndrome and cancer, it is critical to clarify the functional role of PPARbeta/delta in cell proliferation and associated disorders such as cancer. However, there is considerable controversy whether PPARbeta/delta stimulates or inhibits cell proliferation. This review summarizes the literature describing the influence of PPARbeta/delta on cell proliferation, with an emphasis toward dissecting the data that give rise to opposing hypotheses. Suggestions are offered to standardize measurements associated with these studies so that interlaboratory comparisons can be accurately assessed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19505534      PMCID: PMC2762441          DOI: 10.1016/j.bbcan.2009.06.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  119 in total

1.  Critical roles of PPAR beta/delta in keratinocyte response to inflammation.

Authors:  N S Tan; L Michalik; N Noy; R Yasmin; C Pacot; M Heim; B Flühmann; B Desvergne; W Wahli
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

2.  ERK5 activation inhibits inflammatory responses via peroxisome proliferator-activated receptor delta (PPARdelta) stimulation.

Authors:  Chang-Hoon Woo; Michael P Massett; Tetsuro Shishido; Seigo Itoh; Bo Ding; Carolyn McClain; Wenyi Che; Sreesatya Raju Vulapalli; Chen Yan; Jun-ichi Abe
Journal:  J Biol Chem       Date:  2006-08-30       Impact factor: 5.157

3.  Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery.

Authors:  Lucie H Clapp; Paul Finney; Sally Turcato; Sandy Tran; Lewis J Rubin; Andrew Tinker
Journal:  Am J Respir Cell Mol Biol       Date:  2002-02       Impact factor: 6.914

4.  Id2 gene-targeted crosstalk between Wnt and retinoid signaling regulates proliferation in human keratinocytes.

Authors:  A Memezawa; I Takada; K Takeyama; M Igarashi; S Ito; S Aiba; S Kato; A P Kouzmenko
Journal:  Oncogene       Date:  2007-02-19       Impact factor: 9.867

5.  Differential effects of retinoids on DNA synthesis in calcium-regulated murine epidermal keratinocyte cultures.

Authors:  P S Tong; D M Mayes; L A Wheeler
Journal:  J Invest Dermatol       Date:  1988-06       Impact factor: 8.551

6.  Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome.

Authors:  Toshiya Tanaka; Joji Yamamoto; Satoshi Iwasaki; Hiroshi Asaba; Hiroki Hamura; Yukio Ikeda; Mitsuhiro Watanabe; Kenta Magoori; Ryoichi X Ioka; Keisuke Tachibana; Yuichiro Watanabe; Yasutoshi Uchiyama; Koichi Sumi; Haruhisa Iguchi; Sadayoshi Ito; Takefumi Doi; Takao Hamakubo; Makoto Naito; Johan Auwerx; Masashi Yanagisawa; Tatsuhiko Kodama; Juro Sakai
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

7.  Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR.

Authors:  Thaddeus T Schug; Daniel C Berry; Illia A Toshkov; Le Cheng; Alexander Yu Nikitin; Noa Noy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-21       Impact factor: 11.205

8.  Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice.

Authors:  L Michalik; B Desvergne; N S Tan; S Basu-Modak; P Escher; J Rieusset; J M Peters; G Kaya; F J Gonzalez; J Zakany; D Metzger; P Chambon; D Duboule; W Wahli
Journal:  J Cell Biol       Date:  2001-08-20       Impact factor: 10.539

9.  The PPARδ ligand GW501516 reduces growth but not apoptosis in mouse inner medullary collecting duct cells.

Authors:  Jordan Clark; Rania Nasrallah; Richard L Hébert
Journal:  PPAR Res       Date:  2009-03-04       Impact factor: 4.964

10.  Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.

Authors:  Moses T Bility; Meghann K Devlin-Durante; Nicholas Blazanin; Adam B Glick; Jerrold M Ward; Boo Hyon Kang; Mary J Kennett; Frank J Gonzalez; Jeffrey M Peters
Journal:  Carcinogenesis       Date:  2008-09-17       Impact factor: 4.741

View more
  58 in total

Review 1.  The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.

Authors:  Jeffrey M Peters; Yatrik M Shah; Frank J Gonzalez
Journal:  Nat Rev Cancer       Date:  2012-02-09       Impact factor: 60.716

2.  Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.

Authors:  Adeline Péchery; Sylvie Fauconnet; Hugues Bittard; Isabelle Lascombe
Journal:  Tumour Biol       Date:  2016-09-16

3.  Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.

Authors:  Michael G Borland; Prasad Krishnan; Christina Lee; Prajakta P Albrecht; Weiwei Shan; Moses T Bility; Craig B Marcus; Jyh M Lin; Shantu Amin; Frank J Gonzalez; Gary H Perdew; Jeffrey M Peters
Journal:  Carcinogenesis       Date:  2014-03-17       Impact factor: 4.944

4.  Peroxisome proliferator-activated receptor β/δ cross talks with E2F and attenuates mitosis in HRAS-expressing cells.

Authors:  Bokai Zhu; Combiz Khozoie; Moses T Bility; Christina H Ferry; Nicholas Blazanin; Adam B Glick; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

5.  Transcriptional profiling identifies functional interactions of TGF β and PPAR β/δ signaling: synergistic induction of ANGPTL4 transcription.

Authors:  Kerstin Kaddatz; Till Adhikary; Florian Finkernagel; Wolfgang Meissner; Sabine Müller-Brüsselbach; Rolf Müller
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

Review 6.  Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities.

Authors:  Curtis J Omiecinski; John P Vanden Heuvel; Gary H Perdew; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2010-11-08       Impact factor: 4.849

Review 7.  Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.

Authors:  Jeffrey M Peters; Jennifer E Foreman; Frank J Gonzalez
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

8.  Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.

Authors:  Pei-Li Yao; Jose L Morales; Bokai Zhu; Boo-Hyon Kang; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Cancer Ther       Date:  2014-01-24       Impact factor: 6.261

9.  Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity.

Authors:  Shannon E Dunn; Roopa Bhat; Daniel S Straus; Raymond A Sobel; Robert Axtell; Amanda Johnson; Kim Nguyen; Lata Mukundan; Marina Moshkova; Jason C Dugas; Ajay Chawla; Lawrence Steinman
Journal:  J Exp Med       Date:  2010-07-12       Impact factor: 17.579

10.  A metabolic prosurvival role for PML in breast cancer.

Authors:  Arkaitz Carracedo; Dror Weiss; Amy K Leliaert; Manoj Bhasin; Vincent C J de Boer; Gaelle Laurent; Andrew C Adams; Maria Sundvall; Su Jung Song; Keisuke Ito; Lydia S Finley; Ainara Egia; Towia Libermann; Zachary Gerhart-Hines; Pere Puigserver; Marcia C Haigis; Elefteria Maratos-Flier; Andrea L Richardson; Zachary T Schafer; Pier P Pandolfi
Journal:  J Clin Invest       Date:  2012-08-13       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.